Chronic spontaneous urticaria (CSU) is perceived as a difficult to manage disease with negative impact on quality of life. The aim of this study was to highlight how to improve the care of people with CSU, using the methodology of narrative medicine. From June 2014 to March 2015, CSU-diagnosed patients and their physicians were asked to record...
-
2016 (v1)PublicationUploaded on: April 14, 2023
-
2021 (v1)Publication
Background Because Myroxylon pereirae (MP), or balsam of Peru, is nowadays almost not used "as such," and fragrance mix 1 (FM1) apparently is more sensitive in detecting fragrance allergy, the usefulness of testing MP in baseline series was recently questioned.Objectives Identification of the number of clinically relevant patch-test reactions...
Uploaded on: February 14, 2024 -
2021 (v1)Publication
Alitretinoin is the only systemic agent approved to treat moderate-severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids. No nationwide Italian data regarding real-life efficacy, safety, and tolerability of treatment are available. The DECISA project (DErmatology Clinics in Italy: Survey on Alitretinoin)...
Uploaded on: February 14, 2024 -
2018 (v1)Publication
Background There is a need for validated tools to assess health-related quality of life (HRQoL) in routine clinical practice. Objective The aim of this study was to validate the Chronic Urticaria Patient Perspective (CUPP) for assessment of patients with chronic urticaria (CU) in clinical practice. Methods A provisional CUPP was developed from...
Uploaded on: April 14, 2023